Equasens Société anonyme (EPA:EQS)
France · Delayed Price · Currency is EUR 50.50
-0.40 (-0.79%)
Jul 25, 2025, 5:35 PM CET
Equasens Société anonyme Revenue
In the year 2024, Equasens Société anonyme had annual revenue of 216.75M EUR, down -1.38%. Equasens Société anonyme had revenue of 107.17M in the half year ending December 31, 2023, with 8.07% growth.
Revenue
216.75M
Revenue Growth
+1.25%
P/S Ratio
3.50
Revenue / Employee
153.07K
Employees
1,416
Market Cap
759.09M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 216.75M | -3.04M | -1.38% |
| Dec 31, 2023 | 219.79M | 5.71M | 2.67% |
| Dec 31, 2022 | 214.08M | 21.01M | 10.88% |
| Dec 31, 2021 | 193.07M | 21.32M | 12.41% |
| Dec 31, 2020 | 171.75M | 13.19M | 8.31% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| EssilorLuxottica Société anonyme | 26.51B |
| Sanofi | 45.17B |
| Sartorius Stedim Biotech | 2.90B |
| bioMérieux | 3.98B |
| Eurofins Scientific SE | 7.14B |
| Ipsen | 3.57B |
| ABIVAX Société Anonyme | 10.59M |
| Virbac | 1.40B |